Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines - Mohamed El-Tanani; Shakta Mani Satyam; Syed Arman Rabbani; Yahia El-Tanani; Mark Sutherland; Frezah Muhana (PLoS ONE, 2025)